Skip to main content
ABCT 2025 59th Annual Convention Main banner
Psychology Tools Ad
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded Session
Recorded Session
Ticketed Session
Ticketed Session
Evaluation ViewAttendees 19

Clinical Round Tables

Treatment - CBT

Clinical Round Table 4 - Augmenting CBT with Psychedelics

Friday, November 21, 2025
3:00 PM - 4:30 PM CST
Location: Empire D, Level 2
Earn 1.5 Credit
Keywords: Treatment, Treatment Development,
Recommended Readings: Yaden, D. B., Earp, D., Graziosi, M., Friedman-Wheeler, D., Luoma, J. B., & Johnson, M. W. (2022). Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default. Frontiers in psychology, 13, 873279. https://doi.org/10.3389/fpsyg.2022.873279,   Luoma, J. B., Chwyl, C., Bathje, G. J., Davis, A. K., & Lancelotta, R. (2020). A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy. Journal of psychoactive drugs, 52(4), 289–299. https://doi.org/10.1080/02791072.2020.1769878,   Cavarra, M., Falzone, A., Ramaekers, J. G., Kuypers, K. P. C., & Mento, C. (2022). Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions. Frontiers in psychology, 13, 887255. https://doi.org/10.3389/fpsyg.2022.887255,   ,  
Recent clinical trials of psychedelic-assisted therapy (PAT) demonstrate promising results for various mental health conditions, yet questions remain about optimizing the therapy components of these novel treatments. This Clinical Round Table brings together researchers and clinicians to examine how psychedelic substances can be effectively integrated into CBT to enhance outcomes. Panelists will first present the basic model of PAT and emerging evidence supporting CBT-informed approaches, highlighting the unique social and relational learning potential of psychedelic medicines. The discussion will then focus on several specific applications: social anxiety, depression, trauma, and couples therapy. For social anxiety, speakers will describe an iterative treatment development process that evolved from nondirective to CBT-informed approaches, including specific adaptations for preparation, dosing sessions, and integration work. For depression, panelists will discuss how CBT has been used to enhance psilocybin-assisted therapy protocols to treat depressive symptoms and improve psychosocial functioning. For trauma, panelists will discuss how CPT and ketamine-assisted psychotherapy can be successfully incorporated in trauma groups to improve learning of DBT and CPT skills. Finally, for couples therapy, panelists will explore how CBT mechanisms of relationship distress can be addressed through PAT, including assessment strategies, dyadic dosing considerations, and integration methods. Throughout the discussion, emphasis will be placed on practical clinical considerations, case examples, and future directions for research and practice. Special emphasis will be placed on working with diverse clients and tailoring CBT-informed psychedelic-assisted therapy to meet the unique needs of individuals from different cultural backgrounds, gender and sexual identities, and clinical presentations. Audience participation will be encouraged to explore challenges and opportunities in combining these therapeutic approaches.

Learning Objectives:

At the end of this session, the learner will be able to:
  1. Identify how psychedelics can be incorporated into existing CBT frameworks to enhance therapeutic outcomes.
  2. Evaluate current evidence for how psychedelics may augment CBT interventions and enhance processes of change in treating mental health problems.
  3. Develop strategies for tailoring CBT-informed psychedelic-assisted therapy to meet the needs of diverse clients and marginalized populations.